Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Pharmacology Research & Perspectives|August 18, 2025
Saliva Based Clozapine Therapeutic Drug Monitoring: A Systematic ReviewTessa Rademaker, Rachel Chu, Suhaila Hasan, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 11, 2022
Validation of a simplified intravascular ultrasound core lab analysis method in stented coronary arteriesTara Neleman, Jamal Khachabi, Hans Jonker, et al.
Clinical Pharmacokinetics|October 21, 2025
How is Levetiracetam Monotherapy Currently Monitored in Pregnancy? A Systematic ReviewTessa Rademaker, Yeonkyung Goo, May Ching Soh, et al.
The American Journal of Cardiology|August 30, 2016
Frequency of Stent Thrombosis Risk at 5 Years in Women Versus Men With Zotarolimus-Eluting Compared With Sirolimus-Eluting StentMonique Ten Haaf, Yolande Appelman, William Wijns, et al.
European Heart Journal|March 15, 2014
Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent typeEdoardo Camenzind, Eric Boersma, William Wijns, et al.
Journal of the American Heart Association|November 20, 2023
Quality of Life After Percutaneous Coronary Intervention Versus Coronary Artery Bypass GraftingArnaldo Dimagli, Cristiano Spadaccio, Annie Myers, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 22, 2011
Influence of age on the clinical outcomes of coronary revascularisation for the treatment of patients with multivessel de novo coronary artery lesions: sirolimus-eluting stent vs. coronary artery bypass surgery and bare metal stent, insight from the multicentre randomised Arterial Revascularisation Therapy Study Part I (ARTS-I) and Part II (ARTS-II)Victor M Legrand, Scot Garg, Patrick W Serruys, et al.
Diabetes|March 2, 2002
A genome-wide search for linkage-disequilibrium with type 1 diabetes in a recent genetically isolated population from the NetherlandsNorbert Vaessen, Peter Heutink, Jeanine J Houwing-Duistermaat, et al.
Journal of Thrombosis and Thrombolysis|June 9, 2009
Effect of clopidogrel discontinuation at 1 year after drug eluting stent placement on soluble CD40L, P-selectin and C-reactive protein levels: DECADES (Discontinuation Effect of Clopidogrel After Drug Eluting Stent): a multicenter, open-label studyJoanna J Wykrzykowska, Ascan Warnholtz, Peter de Jaeger, et al.
Journal of the American College of Cardiology|February 23, 2010
5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesionsPatrick W Serruys, Yoshinobu Onuma, Scot Garg, et al.
Pageof 3